Showing results (221-230 of 381) with videos related to

Sort By:
Pageof 39
Virology|May 22, 2003
A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropismKoichi Takayama, Paul N Reynolds, Joshua J Short, et al.
Virology|July 3, 2004
Transport across a polarized monolayer of Caco-2 cells by transferrin receptor-mediated adenovirus transcytosisZeng B Zhu, Sharmila K Makhija, Baogen Lu, et al.
Cancer Biology & Therapy|March 12, 2009
Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24Luni Emdad, Irina V Lebedeva, Zhao-zhong Su, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
Adenoviral vector-mediated augmentation of epidermal growth factor receptor (EGFr) enhances the radiosensitization properties of anti-EGFr treatment in prostate cancer cellsJames A Bonner, Donald J Buchsbaum, Buck E Rogers, et al.
Molecular Cancer Therapeutics|September 21, 2006
Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirusMatthew A Tyler, Ilya V Ulasov, Anton Borovjagin, et al.
Annals of Surgery|November 25, 2003
A genetically retargeted adenoviral vector enhances viral transduction in esophageal carcinoma cell lines and primary cultured esophageal resection specimensChristianne J Buskens, Willem A Marsman, John G Wesseling, et al.
Molecular Cancer Therapeutics|September 16, 2008
Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95Margaret A Park, Guo Zhang, Clint Mitchell, et al.
Cancer Biology & Therapy|February 16, 2011
Resistance of canine lymphoma cells to adenoviral infection due to reduced cell surface RGD binding integrinsAnn Marie O'Neill, Annette N Smith, Elizabeth A Spangler, et al.
Gynecologic Oncology|July 12, 2011
Treatment of chemotherapy resistant ovarian cancer with a MDR1 targeted oncolytic adenovirusDaniel T Rein, Anne Volkmer, Ines M Beyer, et al.
The Journal of Biological Chemistry|January 15, 2002
YB-1 relocates to the nucleus in adenovirus-infected cells and facilitates viral replication by inducing E2 gene expression through the E2 late promoterPer S Holm, Stephan Bergmann, Karsten Jurchott, et al.
Pageof 39